NCT00276913View on ClinicalTrials.gov

A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2004

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG

STA-5312

Trial Locations (1)

28203

Steven Limentani, MD, Charlotte

All Listed Sponsors

lead

Synta Pharmaceuticals Corp.

INDUSTRY

NCT00276913 - A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter